Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 118 entries
Sorted by: Best Match Show Resources per page
Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine.

Open forum infectious diseases

Chamcha V, Kannanganat S, Gangadhara S, Nabi R, Kozlowski PA, Montefiori DC, LaBranche CC, Wrammert J, Keele BF, Balachandran H, Sahu S, Lifton M, Santra S, Basu R, Moss B, Robinson HL, Amara RR.
PMID: 27006959
Open Forum Infect Dis. 2016 Feb 11;3(1):ofw034. doi: 10.1093/ofid/ofw034. eCollection 2016 Jan.

Background.  In this study, we analyzed the protective efficacy of a simian immunodeficiency virus (SIV) macaque 239 (SIVmac239) analogue of the clinically tested GOVX-B11 deoxyribonucleic acid (DNA)/modified vaccinia Ankara (MVA) human immunodeficiency virus vaccine. Methods.  The tested vaccine used...

Cite
Chamcha V, Kannanganat S, Gangadhara S, et al. Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine. Open Forum Infect Dis. 2016;3(1):ofw034doi: 10.1093/ofid/ofw034.
Chamcha, V., Kannanganat, S., Gangadhara, S., Nabi, R., Kozlowski, P. A., Montefiori, D. C., LaBranche, C. C., Wrammert, J., Keele, B. F., Balachandran, H., Sahu, S., Lifton, M., Santra, S., Basu, R., Moss, B., Robinson, H. L., & Amara, R. R. (2016). Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine. Open forum infectious diseases, 3(1), ofw034. https://doi.org/10.1093/ofid/ofw034
Chamcha, Venkateswarlu, et al. "Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine." Open forum infectious diseases vol. 3,1 (2016): ofw034. doi: https://doi.org/10.1093/ofid/ofw034
Chamcha V, Kannanganat S, Gangadhara S, Nabi R, Kozlowski PA, Montefiori DC, LaBranche CC, Wrammert J, Keele BF, Balachandran H, Sahu S, Lifton M, Santra S, Basu R, Moss B, Robinson HL, Amara RR. Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine. Open Forum Infect Dis. 2016 Feb 11;3(1):ofw034. doi: 10.1093/ofid/ofw034. eCollection 2016 Jan. PMID: 27006959; PMCID: PMC4800464.
Copy Download .nbib Format: NLM
Fast Methods for Prediction of Aldehyde Oxidase-Mediated Site-of-Metabolism.

Computational and structural biotechnology journal

Montefiori M, Lyngholm-Kjærby C, Long A, Olsen L, Jørgensen FS.
PMID: 30949305
Comput Struct Biotechnol J. 2019 Mar 07;17:345-351. doi: 10.1016/j.csbj.2019.03.003. eCollection 2019.

Aldehyde Oxidase (AO) is an enzyme involved in the metabolism of aldehydes and

Cite
Montefiori M, Lyngholm-Kjærby C, Long A, et al. Fast Methods for Prediction of Aldehyde Oxidase-Mediated Site-of-Metabolism. Comput Struct Biotechnol J. 2019;17:345-351doi: 10.1016/j.csbj.2019.03.003.
Montefiori, M., Lyngholm-Kjærby, C., Long, A., Olsen, L., & Jørgensen, F. S. (2019). Fast Methods for Prediction of Aldehyde Oxidase-Mediated Site-of-Metabolism. Computational and structural biotechnology journal, 17345-351. https://doi.org/10.1016/j.csbj.2019.03.003
Montefiori, Marco, et al. "Fast Methods for Prediction of Aldehyde Oxidase-Mediated Site-of-Metabolism." Computational and structural biotechnology journal vol. 17 (2019): 345-351. doi: https://doi.org/10.1016/j.csbj.2019.03.003
Montefiori M, Lyngholm-Kjærby C, Long A, Olsen L, Jørgensen FS. Fast Methods for Prediction of Aldehyde Oxidase-Mediated Site-of-Metabolism. Comput Struct Biotechnol J. 2019 Mar 07;17:345-351. doi: 10.1016/j.csbj.2019.03.003. eCollection 2019. PMID: 30949305; PMCID: PMC6429535.
Copy Download .nbib Format: NLM
Reliability of an Integrated Ultrasound and Stereophotogrammetric System for Lower Limb Anatomical Characterisation.

Applied bionics and biomechanics

Greatrex F, Montefiori E, Grupp T, Kozak J, Mazzà C.
PMID: 28706440
Appl Bionics Biomech. 2017;2017:4370649. doi: 10.1155/2017/4370649. Epub 2017 Jun 19.

BACKGROUND: Lower extremity analysis for preoperative total knee and hip arthroplasty routines can increase surgery success rate and hence reduce associated costs. Current tools are limited by being invasive, limited to supine analysis, or too expensive. This study aimed...

Cite
Greatrex F, Montefiori E, Grupp T, et al. Reliability of an Integrated Ultrasound and Stereophotogrammetric System for Lower Limb Anatomical Characterisation. Appl Bionics Biomech. 2017;2017:4370649doi: 10.1155/2017/4370649.
Greatrex, F., Montefiori, E., Grupp, T., Kozak, J., & Mazzà, C. (2017). Reliability of an Integrated Ultrasound and Stereophotogrammetric System for Lower Limb Anatomical Characterisation. Applied bionics and biomechanics, 20174370649. https://doi.org/10.1155/2017/4370649
Greatrex, Frederick, et al. "Reliability of an Integrated Ultrasound and Stereophotogrammetric System for Lower Limb Anatomical Characterisation." Applied bionics and biomechanics vol. 2017 (2017): 4370649. doi: https://doi.org/10.1155/2017/4370649
Greatrex F, Montefiori E, Grupp T, Kozak J, Mazzà C. Reliability of an Integrated Ultrasound and Stereophotogrammetric System for Lower Limb Anatomical Characterisation. Appl Bionics Biomech. 2017;2017:4370649. doi: 10.1155/2017/4370649. Epub 2017 Jun 19. PMID: 28706440; PMCID: PMC5494551.
Copy Download .nbib Format: NLM
Oligomannose Glycopeptide Conjugates Elicit Antibodies Targeting the Glycan Core Rather than Its Extremities.

ACS central science

Nguyen DN, Xu B, Stanfield RL, Bailey JK, Horiya S, Temme JS, Leon DR, LaBranche CC, Montefiori DC, Costello CE, Wilson IA, Krauss IJ.
PMID: 30834312
ACS Cent Sci. 2019 Feb 27;5(2):237-249. doi: 10.1021/acscentsci.8b00588. Epub 2019 Feb 06.

Up to ∼20% of HIV-infected individuals eventually develop broadly neutralizing antibodies (bnAbs), and many of these antibodies (∼40%) target a region of dense high-mannose glycosylation on gp120 of the HIV envelope protein, known as the "high-mannose patch" (HMP). Thus,...

Cite
Nguyen DN, Xu B, Stanfield RL, et al. Oligomannose Glycopeptide Conjugates Elicit Antibodies Targeting the Glycan Core Rather than Its Extremities. ACS Cent Sci. 2019;5(2):237-249doi: 10.1021/acscentsci.8b00588.
Nguyen, D. N., Xu, B., Stanfield, R. L., Bailey, J. K., Horiya, S., Temme, J. S., Leon, D. R., LaBranche, C. C., Montefiori, D. C., Costello, C. E., Wilson, I. A., & Krauss, I. J. (2019). Oligomannose Glycopeptide Conjugates Elicit Antibodies Targeting the Glycan Core Rather than Its Extremities. ACS central science, 5(2), 237-249. https://doi.org/10.1021/acscentsci.8b00588
Nguyen, Dung N, et al. "Oligomannose Glycopeptide Conjugates Elicit Antibodies Targeting the Glycan Core Rather than Its Extremities." ACS central science vol. 5,2 (2019): 237-249. doi: https://doi.org/10.1021/acscentsci.8b00588
Nguyen DN, Xu B, Stanfield RL, Bailey JK, Horiya S, Temme JS, Leon DR, LaBranche CC, Montefiori DC, Costello CE, Wilson IA, Krauss IJ. Oligomannose Glycopeptide Conjugates Elicit Antibodies Targeting the Glycan Core Rather than Its Extremities. ACS Cent Sci. 2019 Feb 27;5(2):237-249. doi: 10.1021/acscentsci.8b00588. Epub 2019 Feb 06. PMID: 30834312; PMCID: PMC6396197.
Copy Download .nbib Format: NLM
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques.

Molecular therapy. Nucleic acids

Pardi N, LaBranche CC, Ferrari G, Cain DW, Tombácz I, Parks RJ, Muramatsu H, Mui BL, Tam YK, Karikó K, Polacino P, Barbosa CJ, Madden TD, Hope MJ, Haynes BF, Montefiori DC, Hu SL, Weissman D.
PMID: 30974332
Mol Ther Nucleic Acids. 2019 Apr 15;15:36-47. doi: 10.1016/j.omtn.2019.03.003. Epub 2019 Mar 21.

Despite the enormous effort in the development of effective vaccines against HIV-1, no vaccine candidate has elicited broadly neutralizing antibodies in humans. Thus, generation of more effective anti-HIV vaccines is critically needed. Here we characterize the immune responses induced...

Cite
Pardi N, LaBranche CC, Ferrari G, et al. Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques. Mol Ther Nucleic Acids. 2019;15:36-47doi: 10.1016/j.omtn.2019.03.003.
Pardi, N., LaBranche, C. C., Ferrari, G., Cain, D. W., Tombácz, I., Parks, R. J., Muramatsu, H., Mui, B. L., Tam, Y. K., Karikó, K., Polacino, P., Barbosa, C. J., Madden, T. D., Hope, M. J., Haynes, B. F., Montefiori, D. C., Hu, S. L., & Weissman, D. (2019). Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques. Molecular therapy. Nucleic acids, 1536-47. https://doi.org/10.1016/j.omtn.2019.03.003
Pardi, Norbert, et al. "Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques." Molecular therapy. Nucleic acids vol. 15 (2019): 36-47. doi: https://doi.org/10.1016/j.omtn.2019.03.003
Pardi N, LaBranche CC, Ferrari G, Cain DW, Tombácz I, Parks RJ, Muramatsu H, Mui BL, Tam YK, Karikó K, Polacino P, Barbosa CJ, Madden TD, Hope MJ, Haynes BF, Montefiori DC, Hu SL, Weissman D. Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques. Mol Ther Nucleic Acids. 2019 Apr 15;15:36-47. doi: 10.1016/j.omtn.2019.03.003. Epub 2019 Mar 21. PMID: 30974332; PMCID: PMC6454128.
Copy Download .nbib Format: NLM
Author Correction: The oxidative inactivation of FeFe hydrogenase reveals the flexibility of the H-cluster.

Nature chemistry

Fourmond V, Greco C, Sybirna K, Baffert C, Wang PH, Ezanno P, Montefiori M, Bruschi M, Meynial-Salles I, Soucaille P, Blumberger J, Bottin H, De Gioia L, Léger C.
PMID: 31551526
Nat Chem. 2019 Nov;11(11):1067. doi: 10.1038/s41557-019-0350-6.

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Cite
Fourmond V, Greco C, Sybirna K, et al. Author Correction: The oxidative inactivation of FeFe hydrogenase reveals the flexibility of the H-cluster. Nat Chem. 2019;11(11):1067doi: 10.1038/s41557-019-0350-6.
Fourmond, V., Greco, C., Sybirna, K., Baffert, C., Wang, P. H., Ezanno, P., Montefiori, M., Bruschi, M., Meynial-Salles, I., Soucaille, P., Blumberger, J., Bottin, H., De Gioia, L., & Léger, C. (2019). Author Correction: The oxidative inactivation of FeFe hydrogenase reveals the flexibility of the H-cluster. Nature chemistry, 11(11), 1067. https://doi.org/10.1038/s41557-019-0350-6
Fourmond, Vincent, et al. "Author Correction: The oxidative inactivation of FeFe hydrogenase reveals the flexibility of the H-cluster." Nature chemistry vol. 11,11 (2019): 1067. doi: https://doi.org/10.1038/s41557-019-0350-6
Fourmond V, Greco C, Sybirna K, Baffert C, Wang PH, Ezanno P, Montefiori M, Bruschi M, Meynial-Salles I, Soucaille P, Blumberger J, Bottin H, De Gioia L, Léger C. Author Correction: The oxidative inactivation of FeFe hydrogenase reveals the flexibility of the H-cluster. Nat Chem. 2019 Nov;11(11):1067. doi: 10.1038/s41557-019-0350-6. PMID: 31551526.
Copy Download .nbib Format: NLM
Correction for Hraber et al., "Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments".

Journal of virology

Hraber P, Rademeyer C, Williamson C, Seaman MS, Gottardo R, Tang H, Greene K, Gao H, LaBranche C, Mascola JR, Morris L, Montefiori DC, Korber B.
PMID: 29242255
J Virol. 2017 Dec 14;92(1). doi: 10.1128/JVI.01817-17. Print 2018 Jan 01.

No abstract available.

Cite
Hraber P, Rademeyer C, Williamson C, et al. Correction for Hraber et al., "Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments". J Virol. 2017;92(1)doi: 10.1128/JVI.01817-17.
Hraber, P., Rademeyer, C., Williamson, C., Seaman, M. S., Gottardo, R., Tang, H., Greene, K., Gao, H., LaBranche, C., Mascola, J. R., Morris, L., Montefiori, D. C., & Korber, B. (2018). Correction for Hraber et al., "Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments". Journal of virology, 92(1), . https://doi.org/10.1128/JVI.01817-17
Hraber, Peter, et al. "Correction for Hraber et al., "Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments"." Journal of virology vol. 92,1 (2018). doi: https://doi.org/10.1128/JVI.01817-17
Hraber P, Rademeyer C, Williamson C, Seaman MS, Gottardo R, Tang H, Greene K, Gao H, LaBranche C, Mascola JR, Morris L, Montefiori DC, Korber B. Correction for Hraber et al., "Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments". J Virol. 2017 Dec 14;92(1). doi: 10.1128/JVI.01817-17. Print 2018 Jan 01. PMID: 29242255; PMCID: PMC5730795.
Copy Download .nbib Format: NLM
Cold sensitivity of the SARS-CoV-2 spike ectodomain.

bioRxiv : the preprint server for biology

Edwards RJ, Mansouri K, Stalls V, Manne K, Watts B, Parks R, Janowska K, Gobeil SMC, Kopp M, Li D, Lu X, Mu Z, Deyton M, Oguin TH, Sprenz J, Williams W, Saunders K, Montefiori D, Sempowski GD, Henderson R, Alam M, Haynes BF, Acharya P.
PMID: 32699852
bioRxiv. 2020 Oct 13; doi: 10.1101/2020.07.12.199588.

The SARS-CoV-2 spike (S) protein, a primary target for COVID-19 vaccine development, presents its Receptor Binding Domain in two conformations: receptor-accessible "up" or receptor-inaccessible "down" conformations. Here, we report that the commonly used stabilized S ectodomain construct "2P" is...

Cite
Edwards RJ, Mansouri K, Stalls V, et al. Cold sensitivity of the SARS-CoV-2 spike ectodomain. bioRxiv. 2020;doi: 10.1101/2020.07.12.199588.
Edwards, R. J., Mansouri, K., Stalls, V., Manne, K., Watts, B., Parks, R., Janowska, K., Gobeil, S. M. C., Kopp, M., Li, D., Lu, X., Mu, Z., Deyton, M., Oguin, T. H., Sprenz, J., Williams, W., Saunders, K., Montefiori, D., Sempowski, G. D., Henderson, R., Alam, M., Haynes, B. F., & Acharya, P. (2020). Cold sensitivity of the SARS-CoV-2 spike ectodomain. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2020.07.12.199588
Edwards, Robert J, et al. "Cold sensitivity of the SARS-CoV-2 spike ectodomain." bioRxiv : the preprint server for biology vol. (2020). doi: https://doi.org/10.1101/2020.07.12.199588
Edwards RJ, Mansouri K, Stalls V, Manne K, Watts B, Parks R, Janowska K, Gobeil SMC, Kopp M, Li D, Lu X, Mu Z, Deyton M, Oguin TH, Sprenz J, Williams W, Saunders K, Montefiori D, Sempowski GD, Henderson R, Alam M, Haynes BF, Acharya P. Cold sensitivity of the SARS-CoV-2 spike ectodomain. bioRxiv. 2020 Oct 13; doi: 10.1101/2020.07.12.199588. PMID: 32699852; PMCID: PMC7373133.
Copy Download .nbib Format: NLM
Aldehyde Oxidase: Reaction Mechanism and Prediction of Site of Metabolism.

ACS omega

Montefiori M, Jørgensen FS, Olsen L.
PMID: 30023718
ACS Omega. 2017 Aug 31;2(8):4237-4244. doi: 10.1021/acsomega.7b00658. Epub 2017 Aug 04.

Aldehyde oxidase (AO) is a molybdenum-containing enzyme involved in the clearance of drug compounds containing aldehydes and N-containing heterocyclic fragments. AO has gained considerable interest in recent years because of examples of too fast clearance of drug compounds in...

Cite
Montefiori M, Jørgensen FS, Olsen L. Aldehyde Oxidase: Reaction Mechanism and Prediction of Site of Metabolism. ACS Omega. 2017;2(8):4237-4244doi: 10.1021/acsomega.7b00658.
Montefiori, M., Jørgensen, F. S., & Olsen, L. (2017). Aldehyde Oxidase: Reaction Mechanism and Prediction of Site of Metabolism. ACS omega, 2(8), 4237-4244. https://doi.org/10.1021/acsomega.7b00658
Montefiori, Marco, et al. "Aldehyde Oxidase: Reaction Mechanism and Prediction of Site of Metabolism." ACS omega vol. 2,8 (2017): 4237-4244. doi: https://doi.org/10.1021/acsomega.7b00658
Montefiori M, Jørgensen FS, Olsen L. Aldehyde Oxidase: Reaction Mechanism and Prediction of Site of Metabolism. ACS Omega. 2017 Aug 31;2(8):4237-4244. doi: 10.1021/acsomega.7b00658. Epub 2017 Aug 04. PMID: 30023718; PMCID: PMC6044498.
Copy Download .nbib Format: NLM
Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing Activity.

Vaccines

Pincus SH, Craig RB, Weachter L, LaBranche CC, Nabi R, Watt C, Raymond M, Peters T, Song K, Maresh GA, Montefiori DC, Kozlowski PA.
PMID: 34358190
Vaccines (Basel). 2021 Jul 12;9(7). doi: 10.3390/vaccines9070774.

We have constructed bispecific immunoglobulin-like immunoadhesins that bind to both the HIV-envelope glycoproteins: gp120 and gp41. These immunoadhesins have N terminal domains of human CD4 engrafted onto the N-terminus of the heavy chain of human anti-gp41 mAb 7B2. Binding...

Cite
Pincus SH, Craig RB, Weachter L, et al. Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing Activity. Vaccines (Basel). 2021;9(7)doi: 10.3390/vaccines9070774.
Pincus, S. H., Craig, R. B., Weachter, L., LaBranche, C. C., Nabi, R., Watt, C., Raymond, M., Peters, T., Song, K., Maresh, G. A., Montefiori, D. C., & Kozlowski, P. A. (2021). Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing Activity. Vaccines, 9(7), . https://doi.org/10.3390/vaccines9070774
Pincus, Seth H, et al. "Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing Activity." Vaccines vol. 9,7 (2021). doi: https://doi.org/10.3390/vaccines9070774
Pincus SH, Craig RB, Weachter L, LaBranche CC, Nabi R, Watt C, Raymond M, Peters T, Song K, Maresh GA, Montefiori DC, Kozlowski PA. Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing Activity. Vaccines (Basel). 2021 Jul 12;9(7). doi: 10.3390/vaccines9070774. PMID: 34358190; PMCID: PMC8310024.
Copy Download .nbib Format: NLM
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination.

bioRxiv : the preprint server for biology

Gorman MJ, Patel N, Guebre-Xabier M, Zhu A, Atyeo C, Pullen KM, Loos C, Goez-Gazi Y, Carrion R, Tian JH, Yaun D, Bowman K, Zhou B, Maciejewski S, McGrath ME, Logue J, Frieman MB, Montefiori D, Mann C, Schendel S, Amanat F, Krammer F, Saphire EO, Lauffenburger D, Greene AM, Portnoff AD, Massare MJ, Ellingsworth L, Glenn G, Smith G, Alter G.
PMID: 33564763
bioRxiv. 2021 Feb 05; doi: 10.1101/2021.02.05.429759.

Recently approved vaccines have already shown remarkable protection in limiting SARS-CoV-2 associated disease. However, immunologic mechanism(s) of protection, as well as how boosting alters immunity to wildtype and newly emerging strains, remain incompletely understood. Here we deeply profiled the...

Cite
Gorman MJ, Patel N, Guebre-Xabier M, et al. Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination. bioRxiv. 2021;doi: 10.1101/2021.02.05.429759.
Gorman, M. J., Patel, N., Guebre-Xabier, M., Zhu, A., Atyeo, C., Pullen, K. M., Loos, C., Goez-Gazi, Y., Carrion, R., Tian, J. H., Yaun, D., Bowman, K., Zhou, B., Maciejewski, S., McGrath, M. E., Logue, J., Frieman, M. B., Montefiori, D., Mann, C., Schendel, S., Amanat, F., Krammer, F., Saphire, E. O., Lauffenburger, D., Greene, A. M., Portnoff, A. D., Massare, M. J., Ellingsworth, L., Glenn, G., Smith, G., & Alter, G. (2021). Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2021.02.05.429759
Gorman, Matthew J, et al. "Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination." bioRxiv : the preprint server for biology vol. (2021). doi: https://doi.org/10.1101/2021.02.05.429759
Gorman MJ, Patel N, Guebre-Xabier M, Zhu A, Atyeo C, Pullen KM, Loos C, Goez-Gazi Y, Carrion R, Tian JH, Yaun D, Bowman K, Zhou B, Maciejewski S, McGrath ME, Logue J, Frieman MB, Montefiori D, Mann C, Schendel S, Amanat F, Krammer F, Saphire EO, Lauffenburger D, Greene AM, Portnoff AD, Massare MJ, Ellingsworth L, Glenn G, Smith G, Alter G. Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination. bioRxiv. 2021 Feb 05; doi: 10.1101/2021.02.05.429759. PMID: 33564763; PMCID: PMC7872351.
Copy Download .nbib Format: NLM
Frequent development of broadly neutralizing antibodies in early life in a large cohort of children living with HIV.

The Journal of infectious diseases

Lucier A, Fong Y, Li SH, Dennis M, Eudailey J, Nelson A, Saunders K, Cunningham CK, McFarland E, McKinney R, Moody MA, LaBranche C, Montefiori D, Permar SR, Fouda GG.
PMID: 34962990
J Infect Dis. 2021 Dec 28; doi: 10.1093/infdis/jiab629. Epub 2021 Dec 28.

BACKGROUND: Recent studies have indicated that broadly neutralizing antibodies (bnAbs) in children may develop earlier after HIV infection compared to adults.METHODS: We evaluated plasma from 212 ART-naïve, children living with HIV (1-3 years-old). Neutralization breadth and potency was assessed...

Cite
Lucier A, Fong Y, Li SH, et al. Frequent development of broadly neutralizing antibodies in early life in a large cohort of children living with HIV. J Infect Dis. 2021;doi: 10.1093/infdis/jiab629.
Lucier, A., Fong, Y., Li, S. H., Dennis, M., Eudailey, J., Nelson, A., Saunders, K., Cunningham, C. K., McFarland, E., McKinney, R., Moody, M. A., LaBranche, C., Montefiori, D., Permar, S. R., & Fouda, G. G. (2021). Frequent development of broadly neutralizing antibodies in early life in a large cohort of children living with HIV. The Journal of infectious diseases, . https://doi.org/10.1093/infdis/jiab629
Lucier, Amanda, et al. "Frequent development of broadly neutralizing antibodies in early life in a large cohort of children living with HIV." The Journal of infectious diseases vol. (2021). doi: https://doi.org/10.1093/infdis/jiab629
Lucier A, Fong Y, Li SH, Dennis M, Eudailey J, Nelson A, Saunders K, Cunningham CK, McFarland E, McKinney R, Moody MA, LaBranche C, Montefiori D, Permar SR, Fouda GG. Frequent development of broadly neutralizing antibodies in early life in a large cohort of children living with HIV. J Infect Dis. 2021 Dec 28; doi: 10.1093/infdis/jiab629. Epub 2021 Dec 28. PMID: 34962990.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 118 entries